Doaa S. E. Zaky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Doaa S. E. Zaky has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ahmed M. EL Ghandour
Department of Internal Medicine and Gastroentrology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
1 shared publicationEman R. Zaki
Department of Cardiology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
1 shared publicationEsam M. Bayomy
Department of Internal Medicine and Gastroentrology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
1 shared publication- Eslam. M.A. El- Nahrery
Suez University
1 shared publication Fatma M. Mabrouk
Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
1 shared publicationKhalid A. Mansour
Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 December 2019
- Published by Egyptian Knowledge Bank in Journal of the Egyptian Society of Parasitology
- Vol. 49 (3) , 643-652
USEFULNESS OF CD44 LEVEL AS A BIOMARKER IN DIAGNOSIS OF ACUTE LIVER REJECTION
The incidence of acute and chronic rejection has declined with improvement of immunosuppression regimens in liver transplant recipients. The CD44 protein belongs to a large family of type I Trans membrane glycoproteins and expressed on the surface of most vertebrate cells and is an important receptor for the components of extracellular matrix. The study evaluated if the serum level of CD44 had a value in diagnosis of acute rejection depending on proved rejection by liver biopsy. The patients were recruited from ASCOT from May 2017 to December 2018. They were 20 adults with Post LDLT with elevated liver function tests and were reviewed. The results showed that serum level of CD44 was significantly lower in the rejection group in our study in patient with post liver transplantation. There was highly significant difference between controls & patients as regards serum level of CD44. Negative correlation between serum levels of CD44, WBCs & AST. There was highly significant difference between patients with different pathological findings as regards serum level of CD44. The best cut off point for serum level of CD44 as a marker of rejection was found ≤ 44ng/ml with sensitivity of 85% and specificity of 95% in diagnosis of acute cellular rejection.
- 1 December 2019
- Published by Egyptian Knowledge Bank in Journal of the Egyptian Society of Parasitology
- Vol. 49 (3) , 643-652
Open AccessUSEFULNESS OF CD44 LEVEL AS A BIOMARKER IN DIAGNOSIS OF ACUTE LIVER REJECTION
The incidence of acute and chronic rejection has declined with improvement of immunosuppression regimens in liver transplant recipients. The CD44 protein belongs to a large family of type I Trans membrane glycoproteins and expressed on the surface of most vertebrate cells and is an important receptor for the components of extracellular matrix. The study evaluated if the serum level of CD44 had a value in diagnosis of acute rejection depending on proved rejection by liver biopsy. The patients were recruited from ASCOT from May 2017 to December 2018. They were 20 adults with Post LDLT with elevated liver function tests and were reviewed. The results showed that serum level of CD44 was significantly lower in the rejection group in our study in patient with post liver transplantation. There was highly significant difference between controls & patients as regards serum level of CD44. Negative correlation between serum levels of CD44, WBCs & AST. There was highly significant difference between patients with different pathological findings as regards serum level of CD44. The best cut off point for serum level of CD44 as a marker of rejection was found ≤ 44ng/ml with sensitivity of 85% and specificity of 95% in diagnosis of acute cellular rejection.
- Open Access
- 1 December 2019
- Published by Egyptian Knowledge Bank in Journal of the Egyptian Society of Parasitology
- Vol. 49 (3) , 681-687
OUTCOME OF A LOW-CARBOHYDRATE DIET ON EGYPTIAN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE
Non-alcoholic steatohepatitis (NASH) is a worldwide health problem and imposes a high cost on healthcare system, and NASH is associated with an unhealthy lifestyle. This study investigated whether low carbohydrate diet intervention physical activity and affect intrahepatic fat content and hepatic enzymes. The current interventional study included participants who were over 18 years with NASH (n= 30) with BMI over 25 kg/m2. The effects of proper nutritional therapy (moderate caloric restriction, low carbohydrate) was tested through personal dietary and physical assessment,parameters of the metabolic syndrome and insulin resistance in addition to liver biochemical and imaging study . The assessment was done at baseline and at 3 months by the same observer. The results showed that after 3 months of intervention, patients had a significant decrease in caloric consumption, weight loss (p < 0.001) and HOMA-IR had significant improvements. Lipid profile after 3 months showed significant reduction including cholesterol and triglycerideslevels (p < 0.05). Regarding liver profile significant decrease observed in aminotransferases levels; also there were significant improvements in AST/ALT ratio with decrease in severity of liver steatosis.
- 1 December 2019
- Published by Egyptian Knowledge Bank in Journal of the Egyptian Society of Parasitology
- Vol. 49 (3) , 681-687
Open AccessOUTCOME OF A LOW-CARBOHYDRATE DIET ON EGYPTIAN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE
Non-alcoholic steatohepatitis (NASH) is a worldwide health problem and imposes a high cost on healthcare system, and NASH is associated with an unhealthy lifestyle. This study investigated whether low carbohydrate diet intervention physical activity and affect intrahepatic fat content and hepatic enzymes. The current interventional study included participants who were over 18 years with NASH (n= 30) with BMI over 25 kg/m2. The effects of proper nutritional therapy (moderate caloric restriction, low carbohydrate) was tested through personal dietary and physical assessment,parameters of the metabolic syndrome and insulin resistance in addition to liver biochemical and imaging study . The assessment was done at baseline and at 3 months by the same observer. The results showed that after 3 months of intervention, patients had a significant decrease in caloric consumption, weight loss (p < 0.001) and HOMA-IR had significant improvements. Lipid profile after 3 months showed significant reduction including cholesterol and triglycerideslevels (p < 0.05). Regarding liver profile significant decrease observed in aminotransferases levels; also there were significant improvements in AST/ALT ratio with decrease in severity of liver steatosis.
- Open Access
- 1 June 2016
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 28 (2) , 71-77
The value of YKL-40 in ischemic heart disease patients
- 1 June 2016
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 28 (2) , 71-77
Open AccessThe value of YKL-40 in ischemic heart disease patients
- 1 February 2016
- Published by Elsevier in International Immunopharmacology
- Vol. 31, 105-108
Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity
- 1 February 2016
- Published by Elsevier in International Immunopharmacology
- Vol. 31, 105-108
Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity